ISTH 2021 Congress Archives - Page 91 of 91

Abstract Number: PB1303

Warfarin Anticoagulation and Fetal Central Nervous System Abnormalities: A Case Report

R. Monaheng¹, E. Schapkaitz¹, H. Rhemtula¹, M. Louw¹, A. Gerber¹.
Abstract Number: PB0541

Warfarin Resistance Is Rare but Has Heterogeneous Origin in an Anticoagulation Clinic Population

R. Peck¹, K. Burley¹, L. FitzGibbon¹, C. Doherty², S. Bacon³, R. Thorne², A. Mumford¹
Abstract Number: PB0180

Weight Adjusted Prophylactic to Intermediate Dosed Thromboprophylaxis in COVID-19

M.M Engelen¹, C.P Martens¹, V. Spalart¹, K. Peerlinck¹, R. Willems¹, B. Vandenberk¹, P. De Munter¹, N. Lorent¹, I. Guler², G. Pieters¹, P. Sinonquel¹, J. Vermeulen¹, K. Martinod², P. Verhamme¹, C. Vandenbriele¹, T. Vanassche¹
Abstract Number: PO145

When Therapy with Anticoagulant and Antiplatelet Agents Hides an Acquired Coagulopathy – A Case Report

E. Parcelas¹, F. Francisco¹, M.C. Lobo², J. Esteves²
Abstract Number: PB0143

Whole Blood Assays Demonstrate Reduced Platelet Function in Early SARS-CoV-2 Infection

K. Krauel^1,2, M. Rieder^1,2, N. Baldus^1,2, D. Stallmann^1,2, M. Jeserich^1,2, I. Goller^1,2, L. Wirth³, L. Pollmeier³, M. Hofmann⁴, C. Bode^1,2, H.-J. Busch⁵, B. Schmid⁵, N. Gauchel^1,2, A. Lother^1,2,3, D. Duerschmied^1,2
Abstract Number: LPB0126

Whole Blood Impedance Aggregometry: A Usefool Tool but Still Not the Gold Standard

S. Ellouze¹, C. Lavenu-Bombled², A. Perrier-Cornet², S. Combe², A. Blandinieres², T. Lambert³, R. D'Oiron³, V. Proulle¹
Abstract Number: PB0437

Why Measure von Willebrand Factor Levels for Biological Follow-up of Acquired Haemophilia A Patients?

M. Coulongeat¹, T. Baglo², L. Faucheux², C. Vayne^2,3, F. Maillot¹, N. Ferreira-Maldent¹, C. Pouplard^2,3
Abstract Number: OC 62.1

Women-specific Bleeding in Inherited Platelet Function Defects: A Cross-sectional Study

M.C. Punt¹, N.D. Ruigrok¹, K.W.M. Bloemenkamp², R. Urbanus¹, I.C.L. Kremer Hovinga¹, R.E.G. Schutgens¹, K.P.M. van Galen¹, TIN study group